Substituted fused pyrimidines as antagonists of GPR105 activity

Details for Australian Patent Application No. 2008267724 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Wang, Zhaoyin; De Luca, Jeancarlo; Gareau, Yves; Fortin, Rejean; Li, Lianhai; Truong, Vouy Linh; Beaulieu, Christian; Tranmer, Geoffrey K.; Guay, Daniel; Belley, Michel; Crane, Sheldon N.; Therien, Michel

Agent Spruson & Ferguson

Pub. Number AU-A-2008267724

PCT Pub. Number WO2009/000087

Priority 60/937,792 28.06.07 US

Filing date 26 June 2008

Wipo publication date 31 December 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2009/000087 Priority application(s): WO2009/000087

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008267733-Sequence based engineering and optimization of single chain antibodies

2008267713-Higher pressure, modular target system for radioisotope production